Over the past three years, the COPE project has piloted a strategy that promotes community-driven approaches to reducing the burden of Lassa fever within a One Health research and action framework in South East Nigeria. An integral part of the COPE strategy is the systematic return of research findings to…
Context New and re-emerging infectious diseases pose an ongoing risk to public health. Political instability, climate change, and environmental degradation increase the risk of outbreaks, such as viral haemorrhagic fever. Many countries south of the Sahara, where dangerous pathogens are endemic, have limited resources, inadequate infrastructure, and insufficient capacity to…
Context The Nigeria Centre for Disease Control and Prevention (NCDC) and the Robert Koch Institute (RKI) have been collaborating closely on global health protection for over ten years, with a particular focus on addressing infectious diseases. The GHPP project NiCaDe II (2023-2025) focused on expanding national capacities…
The project “Nigeria Centre for Disease Control: Capacity Development for Preparedness and Response for Infectious Diseases” (NiCaDe) is a longstanding collaboration between the Nigeria Centre for Disease Control and Prevention (NCDC) and the Robert Koch Institute (RKI) since 2019. During its second project phase, the RKI welcomed four…
Context Healthcare systems and animal health services in OH-NET partner countries face a diverse range of challenges. The widespread risk of infection from endemic pathogens with zoonotic potential is as prevalent as the emergence and spread of pathogens with epidemic potential and the development and spread of antimicrobial resistance (AMR).
Context Viral haemorrhagic fevers, especially Lassa fever, cause outbreaks in West Africa, including in Nigeria, Guinea, and Benin. Many referral hospitals face limited intensive care capacity, shortages of essential equipment and supplies, and insufficiently trained staff. This leads to preventable deaths and weak preparedness for larger outbreaks. The MEVIN 2.0…
This page is currently under development. An overview of the project will be published shortly. In the meantime, you are welcome to visit https://ghpp.de/en/projects/ for information about further projects within the GHPP. Thank you for your patience. Facts 01.01.2026 - 31.12.2028…
Context Antimicrobial resistance (AMR) is one of the leading causes of death worldwide: in 2019, approximately 4.95 million deaths were attributable to infections with resistant bacteria. AMR-EFFECT builds directly on its GHPP-predecessor project, WHOCC-AMR, addressing the global challenges of AMR and healthcare-associated infections (HAI). It focuses on the analysis of…
Context The COVID-19 pandemic demonstrated the critical importance of genomic surveillance for protecting public health. By analysing the genetic material of viruses, outbreaks can be detected earlier, transmission pathways can be understood, and effective control measures can be implemented. This is particularly useful, for example, when new variants emerge or…